Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
31
|
pubmed:dateCreated |
1989-11-28
|
pubmed:abstractText |
Two endopeptidases are involved in the conversion of proinsulin; a type I activity directed at the B chain, Arg31,Arg32, C-peptide junction, and type II which cleaves the C-peptide, Lys64,Arg65, A chain junction. To define further the substrate specificities of these enzymes, a series of mutant preproinsulin cDNAs were generated by site-directed and deletion mutagenesis. These were inserted into pT7 plasmids and capped cRNA transcripts synthesized, that were then microinjected into Xenopus oocytes. Oocytes were biosynthetically radiolabeled with [3H]leucine and the secreted peptides (greater than 95% present as unprocessed proinsulins) then incubated with types I and II endopeptidase activities prepared from isolated insulinoma secretory granules. The reaction products were analyzed by high performance liquid chromatography. Des-38-62-proinsulin, in which all but six amino acids of C-peptide were deleted was not processed by either enzyme. The mutant Lys64,Arg65 to Thr64,Arg65 was not cleaved by the type II enzyme but was still a substrate for the type I enzyme. The mutant Arg31,Arg32 to Arg31,Gly32 correspondingly was not cleaved by the type I enzyme; however, in this case it was not attacked by the type II enzyme. These results indicate that not only is the presence of a dibasic sequence essential, but also that the secondary structure of the protein is important in determining whether the prohormone is susceptible to proteolytic processing.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/DNA,
http://linkedlifedata.com/resource/pubmed/chemical/Endopeptidases,
http://linkedlifedata.com/resource/pubmed/chemical/Proinsulin,
http://linkedlifedata.com/resource/pubmed/chemical/RNA,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Complementary,
http://linkedlifedata.com/resource/pubmed/chemical/proinsulin endopeptidase I,
http://linkedlifedata.com/resource/pubmed/chemical/proinsulin endopeptidase II
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0021-9258
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
5
|
pubmed:volume |
264
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
18335-9
|
pubmed:dateRevised |
2009-9-29
|
pubmed:meshHeading |
pubmed-meshheading:2478543-Animals,
pubmed-meshheading:2478543-Base Sequence,
pubmed-meshheading:2478543-Cloning, Molecular,
pubmed-meshheading:2478543-DNA,
pubmed-meshheading:2478543-Endopeptidases,
pubmed-meshheading:2478543-Gene Expression,
pubmed-meshheading:2478543-Mutation,
pubmed-meshheading:2478543-Oocytes,
pubmed-meshheading:2478543-Plasmids,
pubmed-meshheading:2478543-Proinsulin,
pubmed-meshheading:2478543-RNA,
pubmed-meshheading:2478543-RNA, Complementary,
pubmed-meshheading:2478543-Substrate Specificity,
pubmed-meshheading:2478543-Transfection,
pubmed-meshheading:2478543-Xenopus
|
pubmed:year |
1989
|
pubmed:articleTitle |
Proinsulin endopeptidase substrate specificities defined by site-directed mutagenesis of proinsulin.
|
pubmed:affiliation |
Department of Medicine, University of Birmingham, Queen Elizabeth Hospital, United Kingdom.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|